Tracheitis overview: Difference between revisions

Jump to navigation Jump to search
Rija Gul (talk | contribs)
Rija Gul (talk | contribs)
Line 16: Line 16:
==Diagnosis==
==Diagnosis==
===Physical Examination===
===Physical Examination===
Physical examination of patients with tracheitis is usually remarkable for stridor, tracheal tenderness, and intercostal retractions. The may appear toxic, lethargic and in respiratory distress. Coarse crackles can be heard on auscultation of the chest, signifying underlying pneumonia.
Physical examination of patients with tracheitis is usually remarkable for [[stridor]], [[tracheal]] [[tenderness]], and intercostal retractions. The may appear [[toxic]], [[lethargic]] and in respiratory distress. Coarse [[crackles]] can be heard on auscultation of the [[chest]], signifying underlying [[pneumonia]].


==Treatment==
==Treatment==

Revision as of 16:08, 1 July 2020

Tracheitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tracheitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tracheitis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tracheitis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tracheitis overview

CDC on Tracheitis overview

Tracheitis overview in the news

Blogs on Tracheitis overview

Directions to Hospitals Treating Tracheitis

Risk calculators and risk factors for Tracheitis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tracheitis is a bacterial infection of the trachea and is capable of producing airway obstruction.

Causes

Bacterial tracheitis is most often caused by the bacteria Staphylococcus aureus. It frequently follows a recent viral upper respiratory infection. Common causes include

Streptococcus Pyogenes, Haemophilus Influenza, Moraxella Catarrhalis, Mycoplasma Pneumonia, Echoviruses Klebsiella Pneumonia, Adenovirus, Rhinovirus, Coxsakievirus and Influenza virus.

Risk Factors

Common risk factors in the development of tracheitis include pediatric age group, viral upper respiratory tract infection, mechanical ventilation and immunocompromised state. The individuals most likely to be affected are between 2-10 years of age. Staphylococcus Aureus is the most commonly cultured organism on tracheal aspirate. Mechanical ventilation allows easy colonization of the trachea by bacteria and cause tracheitis. Invasive fungal infections commonly develop among immunocompromised individuals and can cause tracheitis.

Diagnosis

Physical Examination

Physical examination of patients with tracheitis is usually remarkable for stridor, tracheal tenderness, and intercostal retractions. The may appear toxic, lethargic and in respiratory distress. Coarse crackles can be heard on auscultation of the chest, signifying underlying pneumonia.

Treatment

Medical Therapy

Treatment of tracheitis involves prompt intiation of antibiotics and clinical assessment of airway. Signs of impending respiratory failure include intercostal retractions, cyanosis, lethargy and confusion. Endotracheal intubation is performed in impending respiratory failure to maintain airway, perform frequent pulmonary toilet and manage acute respiratory failure. Operative bronchoscopy can be performed for direct visualisation of trachea, confirmation of the diagnosis and removal of pseudomembranes. Endotracheal intubation rate has been reported between 38% to 100% and the mean duration of intubation is 3.2 days. It is therefore a crucial part of management of tracheitis which requires judicious assessment of the airway patency and the urgent availability of skills and expertise required for immediate airway intubation. Empiric broad spectrum antibiotics are initially used to control the infection. As the tracheal culture result becomes available the antibiotics can be changed according to the organism isolated. Most commonly isolated organisms include Staphylococcus Aureus, Streptococcus Pneumonia and Moraxella Catarrhalis. Third generation cephalosporin combined with an anti staphylococcal antibiotic e.g Nafcillin, Vancomycin , Clindamycin are included in the initial antibiotic regimen. Current guidelines have outlined a total treatment duration of 10 to 14 days. Supportive respiratory care is provided in less severe clinical presentation. This includes supplemental oxygen ( Sp02=94%)and bronchodilators (Epinephrine or Albuterol). Anti-pyretics can be used for fever. Corticosteroids have not proven benefit but are still used nonetheless.

References

Template:WH Template:WS